Global Cord Blood Corp Files 6-K Report
| Field | Detail |
|---|---|
| Company | Global Cord Blood Corp |
| Form Type | 6-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-private-issuer, regulatory-update, corporate-history
TL;DR
GCBC filed a 6-K, nothing major, just standard foreign issuer update + old court appointment mention.
AI Summary
Global Cord Blood Corporation filed a Form 6-K on June 3, 2025, reporting for the month of June 2025. The filing indicates the company is a foreign private issuer and files annual reports under Form 20-F. It also notes a previous name change from China Cord Blood Corp on July 7, 2009. The filing references an order from the Grand Court of the Cayman Islands dated September 22, 2022, appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited.
Why It Matters
This filing provides routine updates for investors regarding the company's status as a foreign private issuer and references past legal proceedings, offering transparency on its regulatory compliance and corporate history.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily provides administrative and background information, not new financial or operational data.
Key Numbers
- 001-34541 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- Global Cord Blood Corporation (company) — Registrant
- China Cord Blood Corp (company) — Former company name
- Margot MacInnis (person) — Appointed by court
- John Royle (person) — Appointed by court
- Grant Thornton Specialist Services (Cayman) Limited (company) — Firm appointed by court
- Grand Court of the Cayman Islands (company) — Court issuing order
- 001-34541 (dollar_amount) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange, or that it has distributed or is required to distribute to its security holders.
When was Global Cord Blood Corporation previously known as China Cord Blood Corp?
The company's name was changed from China Cord Blood Corp to Global Cord Blood Corporation on July 7, 2009.
Who was appointed by the Grand Court of the Cayman Islands on September 22, 2022?
Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited were appointed by the Grand Court of the Cayman Islands on September 22, 2022.
Does Global Cord Blood Corporation file annual reports under Form 20-F or Form 40-F?
The filing indicates that Global Cord Blood Corporation files annual reports under cover of Form 20-F.
What is the principal executive office address of Global Cord Blood Corporation?
The principal executive offices are located at 48th Floor, Bank of China Tower, 1 Garden Road, Central, Hong Kong S.A.R.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 3, 2025 by Margot MacInnis regarding Global Cord Blood Corp.